Takeda Canada Finalises LoI With PCPA For Antiviral Drug Livtencity
- Stock Market Stocks to buy Stocks to sell
admin
- 0
- 1 minute read
(RTTNews) – Takeda Canada, a subsidiary of Takeda Pharmaceutical Co. Ltd. (TAK), Thursday announced that it has finalized a Letter of Intent with pan-Canadian Pharmaceutical Alliance or pCPA for Livtencity, which is used to treat patients suffering from post-transplant cytomegalo
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-956821300-b29b779991de44d6af762bfb4f909fdf.jpg "<div>Could Google's New Quantum Chip Mean Your Bitcoin Could Soon Be Hacked?</div>")
:max_bytes(150000):strip_icc():format(jpeg)/modern-analyst-1316900_1920-f70c674fb760412fa184a505a51c5c2d.jpg "Common Interview Questions for Credit Risk Analysts")
:max_bytes(150000):strip_icc():format(jpeg)/SECForm425-41087544bb054a868ccbeb13482beb63.jpg "What Does a Chief Financial Officer (CFO) Do?")